Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BHC | Bausch Health Companies Inc. | Director | $11.4M | May 10, 2022 | ||
BLCO | Bausch & Lomb Corp | CEO & Chairman, Director | $8.06M | May 5, 2022 | ||
EBS | Emergent BioSolutions Inc. | President and CEO, Director | $0 | Mar 13, 2024 | ||
CADL | Candel Therapeutics, Inc. | Director | Jun 26, 2024 | |||
MIST | Milestone Pharmaceuticals Inc. | Director | Sep 3, 2024 | |||
RXDX | Prometheus Biosciences, Inc. | Director | Jun 16, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|